Tag
DEA
- DEA judge stays marijuana rescheduling hearing over GAO report motion
- Trulieve set to become first NYSE-listed cannabis company
- Cannabis stocks swing wildly on U.S. rescheduling news
- American DEA boosts psychedelic drug production quotas
- California governor signs bill to promote state psychedelics research
- Overwhelming majority think rescheduling will occur under Trump: ATB survey
- Cannabis stocks and ETFs rally as Trump considers rescheduling
- Psychedelic drug developer Cybin secures major financing deal
- Cannabis stocks slide after DEA decides to push back reclassification hearing
- Historic cannabis rescheduling imminent in the U.S., multiple sources say
- DEA sharply increases quantities of psychedelics, cannabinoids for 2024 research
- U.S. health department urges DEA to re‑classify cannabis as a less dangerous substance
- DEA proposes hiking Schedule I drug production for medical research
- US DEA suggests big increase of cannabis and psilocybin production for research
- Cannabis research centre opens at Washington State University
- Low‑THC weed led to poor results in major PTSD study
- Company study suggests inhalation of CBD safer than ingestion
- DEA given police-like power to uphold federal law during protests
- U.S. FDA gives rare designation to THC cancer drug in clinical trials